China CDC Issues Flu Vaccination Q&A

This is a public-health communication event, not a market catalyst, but it signals official attention to seasonal flu risk in China. For RWA or crypto markets, the direct relevance is negligible unless it feeds into broader narratives about health-sector policy or data flows. The meaningful angle is whether this Q&A precedes more aggressive vaccination campaigns or supply-chain moves, which could indirectly affect biotech or pharma-related assets. Watch for follow-up announcements on vaccine procurement or distribution logistics, as those would carry more tangible market implications than the guidance itself.